COVID-19 & CancerFree Class of drugs used to treat CAR T-cell toxicity may reduce COVID-19 deathsTwo randomized trials announced March 24, 2020Vol.46 No.13By Paul Goldberg
Drugs & TargetsFree China accepts sNDA for Zejula in ovarian cancer indication March 20, 2020Vol.46 No.12
Drugs & TargetsFree The U.K. removes Keytruda from Cancer Drug Fund in bladder cancer indication March 20, 2020Vol.46 No.12
Drugs & TargetsFree FDA approves Herzuma, equivalent of Herceptin, in indications March 20, 2020Vol.46 No.12
Clinical RoundupFree Pembrolizumab shows promise for some advanced, hard-to-treat rare cancers March 20, 2020Vol.46 No.12
Clinical RoundupFree Study suggests link between BMI, nutritional markers, and chemotherapy toxicity in older adults with tumors March 20, 2020Vol.46 No.12
COVID-19 & CancerFreeTrials & Tribulations What community cancer centers need to know about COVID-19 March 20, 2020Vol.46 No.12By Jeff Patton and Lee Schwartzberg
FreeIn Brief NCCN releases recommendations for standardizing quality measurements in oncology March 20, 2020Vol.46 No.12
